Ascent’ Generics Buprenorphine & Naloxone Receives Approval in US
15 Dec 2025 //
FDA
Ascent’s Generics Sodium Oxybate Receives Approval in US
05 Nov 2025 //
FDA
Ascent`s Generics Rivaroxaban Receives Approval in US
14 May 2025 //
FDA
Ascent Pharma`s Generics Carbidopa, Levodopa Receives Approval in US
14 Jan 2025 //
FDA
Ascent Pharma`s Generics Lubiprostone Receives Approval in US
02 Jan 2025 //
FDA

Market Place
Sourcing Support